FDx Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-8,586
Closed -$219K 776
2023
Q2
$219K Buy
+8,586
New +$208K 0.01% 695
2022
Q2
Sell
-8,764
Closed -$242K 902
2022
Q1
$242K Buy
8,764
+2,845
+48% +$81.4K 0.01% 744
2021
Q4
$244K Buy
+5,919
New +$261K 0.01% 778

Other funds holding VCYT

FDx Advisors's VCYT Position: Q3 2023 in Review

FDx Advisors sold out of Veracyte (VCYT) in Q3 2023, closing a stake of 8,586 shares — an estimated $219K sold.

FDx Advisors first reported a position in VCYT in Q4 2021 and held it in 3 quarters. The position peaked at $244K in Q4 2021. 236 funds tracked by Wall St. Rank hold VCYT as of Q3 2023.

  • FDx Advisors reported no remaining Veracyte position as of Q3 2023 after selling out during the quarter.
  • FDx Advisors sold 8,586 Veracyte shares in Q3 2023, an estimated $219K.
  • FDx Advisors first reported a position in Veracyte in Q4 2021 and held it in 3 quarters.
  • FDx Advisors's Veracyte position peaked at $244K in Q4 2021.
  • 236 funds tracked by Wall St. Rank held Veracyte as of Q3 2023.

Based on FDx Advisors's 13F filing for Q3 2023, filed 2 Nov 2023.